https://www.healio.com/news/infectious-disease/20231014/rsv-vaccine-remains-effective-across-two-seasons-study-shows
0
0
42 words
0
Comments
BOSTON — GSK’s respiratory syncytial virus vaccine had a sustained effectiveness of around 67% among adults aged 60 years or older across two full RSV seasons, researchers reported at IDWeek.
You are the first to view
Create an account or login to join the discussion